| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 9.807 | 8.738 | 9.552 | 7.560 |
| Total Income - EUR | - | - | - | - | - | - | 9.807 | 8.738 | 9.552 | 7.560 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.498 | 2.987 | 5.508 | 6.055 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 4.309 | 5.750 | 4.043 | 1.505 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 4.021 | 5.514 | 3.141 | 1.106 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Burlica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 875 |
| Current Assets | - | - | - | - | - | - | 4.161 | 5.597 | 3.397 | 3.595 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 0 | 275 |
| Cash | - | - | - | - | - | - | 4.161 | 5.597 | 3.397 | 3.320 |
| Shareholders Funds | - | - | - | - | - | - | 4.061 | 5.555 | 3.197 | 4.285 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 100 | 42 | 200 | 185 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Burlica S.r.l.